Robert Dorkin is the Senior Director of Delivery Technologies at Aera Therapeutics, where they currently lead initiatives in cutting-edge therapeutic solutions. They have served as a Senior Research Scientist at Beam Therapeutics since 2018 and a Research Scientist at CRISPR Therapeutics since 2016. Previously, Robert held the position of Liposomal Platform Lead at STC Biologics Inc from 2015 to 2016 and worked as a Research Associate at Alnylam Pharmaceuticals from 2006 to 2009. Robert earned a Bachelor of Arts in Biochemistry from Swarthmore College and a Doctor of Philosophy in Biology from the Massachusetts Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices